Radioimmunoassay Market to 2027 - Global Analysis and Forecasts By Type (Reagents and Kits, Analyzers Market); Application (Research, Clinical Diagnostics); End User (Hospital, Pharmaceutical Industry and CRO, Academics, Clinical Diagnostic Laboratories)
Report Code: TIPRE00006186 No. of Pages: 150 Category: Biotechnology Status: Upcoming
MARKET INTRODUCTION
Radioimmunoassay (RIA) is an in vitro assay which helps to measures the presence of an antigen with very high sensitivity. In radioimmunoassay radioactive versions of a substance, or isotopes of the substance, are mixed with antibodies and inserted in a sample of the patient's blood. The amount of free isotope is then calculated to see how much of the original substance was in the blood. RIA has many applications, such as narcotics drug detection, blood bank screening for the hepatitis virus, early cancer detection, diagnosis and treatment of peptic ulcers and in research with brain chemicals called neurotransmitters.
MARKET DYNAMICS
The radioimmunoassay market is anticipated to grow in the forecast, the rising use of radioimmunoassay techniques in cancer diagnosis and advancements in medical research. In addition, it is also used in diagnosis of various other infectious diseases including neurodegenerative disorders, increasing RIA procedures in research centers, contract research organizations and pharmaceutical industries is expected to offer significant growth opportunities in the market during the forecast period.
MARKET SCOPE
The "Global Radioimmunoassay (RIA) Market Analysis to 2027" is a specialized and in-depth study of the in biotechnology industry with a special focus on the global market trend analysis. The report aims to provide an overview of radioimmunoassay market with detailed market segmentation by type, by application, end user and geography. The global radioimmunoassay market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading radioimmunoassay market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global radioimmunoassay market is segmented on the basis of by type, by application, end user. Based on type, market is segmented into reagents and kits, analyzers. The radioimmunoassay market is categorized based on application in clinical diagnostics and research. Based on end user hospital, pharmaceutical industry, academics and clinical diagnostic labs.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global radioimmunoassay market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The radioimmunoassay market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting radioimmunoassay market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the radioimmunoassay market in these regions.
The reports cover key developments in the radioimmunoassay market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. Below mentioned is the list of few companies engaged in the radioimmunoassay market.
The report also includes the profiles of key radioimmunoassay market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
1. DIAsource ImmunoAssays
2. Beckman Coulter, Inc.
3. IBL International (A Tecan Company)
4. PerkinElmer, Inc.
5. DRG International, Inc.
6. MP Biomedicals, LLC
7. Cisbio
8. Euro Diagnostica AB
9. DiaSorin S.p.A.
10. EMD Millipore
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
Radioimmunoassay (RIA) is an in vitro assay which helps to measures the presence of an antigen with very high sensitivity. In radioimmunoassay radioactive versions of a substance, or isotopes of the substance, are mixed with antibodies and inserted in a sample of the patient's blood. The amount of free isotope is then calculated to see how much of the original substance was in the blood. RIA has many applications, such as narcotics drug detection, blood bank screening for the hepatitis virus, early cancer detection, diagnosis and treatment of peptic ulcers and in research with brain chemicals called neurotransmitters.
MARKET DYNAMICS
The radioimmunoassay market is anticipated to grow in the forecast, the rising use of radioimmunoassay techniques in cancer diagnosis and advancements in medical research. In addition, it is also used in diagnosis of various other infectious diseases including neurodegenerative disorders, increasing RIA procedures in research centers, contract research organizations and pharmaceutical industries is expected to offer significant growth opportunities in the market during the forecast period.
MARKET SCOPE
The "Global Radioimmunoassay (RIA) Market Analysis to 2027" is a specialized and in-depth study of the in biotechnology industry with a special focus on the global market trend analysis. The report aims to provide an overview of radioimmunoassay market with detailed market segmentation by type, by application, end user and geography. The global radioimmunoassay market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading radioimmunoassay market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global radioimmunoassay market is segmented on the basis of by type, by application, end user. Based on type, market is segmented into reagents and kits, analyzers. The radioimmunoassay market is categorized based on application in clinical diagnostics and research. Based on end user hospital, pharmaceutical industry, academics and clinical diagnostic labs.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global radioimmunoassay market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The radioimmunoassay market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting radioimmunoassay market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the radioimmunoassay market in these regions.
The reports cover key developments in the radioimmunoassay market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. Below mentioned is the list of few companies engaged in the radioimmunoassay market.
The report also includes the profiles of key radioimmunoassay market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
1. DIAsource ImmunoAssays
2. Beckman Coulter, Inc.
3. IBL International (A Tecan Company)
4. PerkinElmer, Inc.
5. DRG International, Inc.
6. MP Biomedicals, LLC
7. Cisbio
8. Euro Diagnostica AB
9. DiaSorin S.p.A.
10. EMD Millipore
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Radioimmunoassay Market - By Type
1.3.2 Radioimmunoassay Market - By Application
1.3.3 Radioimmunoassay Market - By End User
1.3.4 Radioimmunoassay Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. RADIOIMMUNOASSAY MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. RADIOIMMUNOASSAY MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. RADIOIMMUNOASSAY MARKET - GLOBAL MARKET ANALYSIS
6.1. RADIOIMMUNOASSAY - GLOBAL MARKET OVERVIEW
6.2. RADIOIMMUNOASSAY - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. RADIOIMMUNOASSAY MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. REAGENTS AND KITS
7.3.1. Overview
7.3.2. Reagents and Kits Market Forecast and Analysis
7.4. ANALYZERS MARKET
7.4.1. Overview
7.4.2. Analyzers Market Market Forecast and Analysis
8. RADIOIMMUNOASSAY MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. RESEARCH
8.3.1. Overview
8.3.2. Research Market Forecast and Analysis
8.4. CLINICAL DIAGNOSTICS
8.4.1. Overview
8.4.2. Clinical Diagnostics Market Forecast and Analysis
9. RADIOIMMUNOASSAY MARKET - REVENUE AND FORECASTS TO 2027 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. HOSPITAL
9.3.1. Overview
9.3.2. Hospital Market Forecast and Analysis
9.4. PHARMACEUTICAL INDUSTRY AND CRO
9.4.1. Overview
9.4.2. Pharmaceutical Industry and CRO Market Forecast and Analysis
9.5. ACADEMICS
9.5.1. Overview
9.5.2. Academics Market Forecast and Analysis
9.6. CLINICAL DIAGNOSTIC LABORATORIES
9.6.1. Overview
9.6.2. Clinical Diagnostic Laboratories Market Forecast and Analysis
10. RADIOIMMUNOASSAY MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Radioimmunoassay Market Overview
10.1.2 North America Radioimmunoassay Market Forecasts and Analysis
10.1.3 North America Radioimmunoassay Market Forecasts and Analysis - By Type
10.1.4 North America Radioimmunoassay Market Forecasts and Analysis - By Application
10.1.5 North America Radioimmunoassay Market Forecasts and Analysis - By End User
10.1.6 North America Radioimmunoassay Market Forecasts and Analysis - By Countries
10.1.6.1 United States Radioimmunoassay Market
10.1.6.1.1 United States Radioimmunoassay Market by Type
10.1.6.1.2 United States Radioimmunoassay Market by Application
10.1.6.1.3 United States Radioimmunoassay Market by End User
10.1.6.2 Canada Radioimmunoassay Market
10.1.6.2.1 Canada Radioimmunoassay Market by Type
10.1.6.2.2 Canada Radioimmunoassay Market by Application
10.1.6.2.3 Canada Radioimmunoassay Market by End User
10.1.6.3 Mexico Radioimmunoassay Market
10.1.6.3.1 Mexico Radioimmunoassay Market by Type
10.1.6.3.2 Mexico Radioimmunoassay Market by Application
10.1.6.3.3 Mexico Radioimmunoassay Market by End User
10.2. EUROPE
10.2.1 Europe Radioimmunoassay Market Overview
10.2.2 Europe Radioimmunoassay Market Forecasts and Analysis
10.2.3 Europe Radioimmunoassay Market Forecasts and Analysis - By Type
10.2.4 Europe Radioimmunoassay Market Forecasts and Analysis - By Application
10.2.5 Europe Radioimmunoassay Market Forecasts and Analysis - By End User
10.2.6 Europe Radioimmunoassay Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Radioimmunoassay Market
10.2.6.1.1 Germany Radioimmunoassay Market by Type
10.2.6.1.2 Germany Radioimmunoassay Market by Application
10.2.6.1.3 Germany Radioimmunoassay Market by End User
10.2.6.2 France Radioimmunoassay Market
10.2.6.2.1 France Radioimmunoassay Market by Type
10.2.6.2.2 France Radioimmunoassay Market by Application
10.2.6.2.3 France Radioimmunoassay Market by End User
10.2.6.3 Italy Radioimmunoassay Market
10.2.6.3.1 Italy Radioimmunoassay Market by Type
10.2.6.3.2 Italy Radioimmunoassay Market by Application
10.2.6.3.3 Italy Radioimmunoassay Market by End User
10.2.6.4 Spain Radioimmunoassay Market
10.2.6.4.1 Spain Radioimmunoassay Market by Type
10.2.6.4.2 Spain Radioimmunoassay Market by Application
10.2.6.4.3 Spain Radioimmunoassay Market by End User
10.2.6.5 United Kingdom Radioimmunoassay Market
10.2.6.5.1 United Kingdom Radioimmunoassay Market by Type
10.2.6.5.2 United Kingdom Radioimmunoassay Market by Application
10.2.6.5.3 United Kingdom Radioimmunoassay Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Radioimmunoassay Market Overview
10.3.2 Asia-Pacific Radioimmunoassay Market Forecasts and Analysis
10.3.3 Asia-Pacific Radioimmunoassay Market Forecasts and Analysis - By Type
10.3.4 Asia-Pacific Radioimmunoassay Market Forecasts and Analysis - By Application
10.3.5 Asia-Pacific Radioimmunoassay Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Radioimmunoassay Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Radioimmunoassay Market
10.3.6.1.1 Australia Radioimmunoassay Market by Type
10.3.6.1.2 Australia Radioimmunoassay Market by Application
10.3.6.1.3 Australia Radioimmunoassay Market by End User
10.3.6.2 China Radioimmunoassay Market
10.3.6.2.1 China Radioimmunoassay Market by Type
10.3.6.2.2 China Radioimmunoassay Market by Application
10.3.6.2.3 China Radioimmunoassay Market by End User
10.3.6.3 India Radioimmunoassay Market
10.3.6.3.1 India Radioimmunoassay Market by Type
10.3.6.3.2 India Radioimmunoassay Market by Application
10.3.6.3.3 India Radioimmunoassay Market by End User
10.3.6.4 Japan Radioimmunoassay Market
10.3.6.4.1 Japan Radioimmunoassay Market by Type
10.3.6.4.2 Japan Radioimmunoassay Market by Application
10.3.6.4.3 Japan Radioimmunoassay Market by End User
10.3.6.5 South Korea Radioimmunoassay Market
10.3.6.5.1 South Korea Radioimmunoassay Market by Type
10.3.6.5.2 South Korea Radioimmunoassay Market by Application
10.3.6.5.3 South Korea Radioimmunoassay Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Radioimmunoassay Market Overview
10.4.2 Middle East and Africa Radioimmunoassay Market Forecasts and Analysis
10.4.3 Middle East and Africa Radioimmunoassay Market Forecasts and Analysis - By Type
10.4.4 Middle East and Africa Radioimmunoassay Market Forecasts and Analysis - By Application
10.4.5 Middle East and Africa Radioimmunoassay Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Radioimmunoassay Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Radioimmunoassay Market
10.4.6.1.1 South Africa Radioimmunoassay Market by Type
10.4.6.1.2 South Africa Radioimmunoassay Market by Application
10.4.6.1.3 South Africa Radioimmunoassay Market by End User
10.4.6.2 Saudi Arabia Radioimmunoassay Market
10.4.6.2.1 Saudi Arabia Radioimmunoassay Market by Type
10.4.6.2.2 Saudi Arabia Radioimmunoassay Market by Application
10.4.6.2.3 Saudi Arabia Radioimmunoassay Market by End User
10.4.6.3 U.A.E Radioimmunoassay Market
10.4.6.3.1 U.A.E Radioimmunoassay Market by Type
10.4.6.3.2 U.A.E Radioimmunoassay Market by Application
10.4.6.3.3 U.A.E Radioimmunoassay Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Radioimmunoassay Market Overview
10.5.2 South and Central America Radioimmunoassay Market Forecasts and Analysis
10.5.3 South and Central America Radioimmunoassay Market Forecasts and Analysis - By Type
10.5.4 South and Central America Radioimmunoassay Market Forecasts and Analysis - By Application
10.5.5 South and Central America Radioimmunoassay Market Forecasts and Analysis - By End User
10.5.6 South and Central America Radioimmunoassay Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Radioimmunoassay Market
10.5.6.1.1 Brazil Radioimmunoassay Market by Type
10.5.6.1.2 Brazil Radioimmunoassay Market by Application
10.5.6.1.3 Brazil Radioimmunoassay Market by End User
10.5.6.2 Argentina Radioimmunoassay Market
10.5.6.2.1 Argentina Radioimmunoassay Market by Type
10.5.6.2.2 Argentina Radioimmunoassay Market by Application
10.5.6.2.3 Argentina Radioimmunoassay Market by End User
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. RADIOIMMUNOASSAY MARKET, KEY COMPANY PROFILES
12.1. DIASOURCE IMMUNOASSAYS
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. BECKMAN COULTER, INC.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. IBL INTERNATIONAL
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. PERKINELMER, INC.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. DRG INTERNATIONAL, INC.
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. MP BIOMEDICALS, LLC
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. CISBIO
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. EURO DIAGNOSTICA AB
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. DIASORIN S.P.A.
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. EMD MILLIPORE
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Radioimmunoassay Market - By Type
1.3.2 Radioimmunoassay Market - By Application
1.3.3 Radioimmunoassay Market - By End User
1.3.4 Radioimmunoassay Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. RADIOIMMUNOASSAY MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. RADIOIMMUNOASSAY MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. RADIOIMMUNOASSAY MARKET - GLOBAL MARKET ANALYSIS
6.1. RADIOIMMUNOASSAY - GLOBAL MARKET OVERVIEW
6.2. RADIOIMMUNOASSAY - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. RADIOIMMUNOASSAY MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. REAGENTS AND KITS
7.3.1. Overview
7.3.2. Reagents and Kits Market Forecast and Analysis
7.4. ANALYZERS MARKET
7.4.1. Overview
7.4.2. Analyzers Market Market Forecast and Analysis
8. RADIOIMMUNOASSAY MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. RESEARCH
8.3.1. Overview
8.3.2. Research Market Forecast and Analysis
8.4. CLINICAL DIAGNOSTICS
8.4.1. Overview
8.4.2. Clinical Diagnostics Market Forecast and Analysis
9. RADIOIMMUNOASSAY MARKET - REVENUE AND FORECASTS TO 2027 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. HOSPITAL
9.3.1. Overview
9.3.2. Hospital Market Forecast and Analysis
9.4. PHARMACEUTICAL INDUSTRY AND CRO
9.4.1. Overview
9.4.2. Pharmaceutical Industry and CRO Market Forecast and Analysis
9.5. ACADEMICS
9.5.1. Overview
9.5.2. Academics Market Forecast and Analysis
9.6. CLINICAL DIAGNOSTIC LABORATORIES
9.6.1. Overview
9.6.2. Clinical Diagnostic Laboratories Market Forecast and Analysis
10. RADIOIMMUNOASSAY MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Radioimmunoassay Market Overview
10.1.2 North America Radioimmunoassay Market Forecasts and Analysis
10.1.3 North America Radioimmunoassay Market Forecasts and Analysis - By Type
10.1.4 North America Radioimmunoassay Market Forecasts and Analysis - By Application
10.1.5 North America Radioimmunoassay Market Forecasts and Analysis - By End User
10.1.6 North America Radioimmunoassay Market Forecasts and Analysis - By Countries
10.1.6.1 United States Radioimmunoassay Market
10.1.6.1.1 United States Radioimmunoassay Market by Type
10.1.6.1.2 United States Radioimmunoassay Market by Application
10.1.6.1.3 United States Radioimmunoassay Market by End User
10.1.6.2 Canada Radioimmunoassay Market
10.1.6.2.1 Canada Radioimmunoassay Market by Type
10.1.6.2.2 Canada Radioimmunoassay Market by Application
10.1.6.2.3 Canada Radioimmunoassay Market by End User
10.1.6.3 Mexico Radioimmunoassay Market
10.1.6.3.1 Mexico Radioimmunoassay Market by Type
10.1.6.3.2 Mexico Radioimmunoassay Market by Application
10.1.6.3.3 Mexico Radioimmunoassay Market by End User
10.2. EUROPE
10.2.1 Europe Radioimmunoassay Market Overview
10.2.2 Europe Radioimmunoassay Market Forecasts and Analysis
10.2.3 Europe Radioimmunoassay Market Forecasts and Analysis - By Type
10.2.4 Europe Radioimmunoassay Market Forecasts and Analysis - By Application
10.2.5 Europe Radioimmunoassay Market Forecasts and Analysis - By End User
10.2.6 Europe Radioimmunoassay Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Radioimmunoassay Market
10.2.6.1.1 Germany Radioimmunoassay Market by Type
10.2.6.1.2 Germany Radioimmunoassay Market by Application
10.2.6.1.3 Germany Radioimmunoassay Market by End User
10.2.6.2 France Radioimmunoassay Market
10.2.6.2.1 France Radioimmunoassay Market by Type
10.2.6.2.2 France Radioimmunoassay Market by Application
10.2.6.2.3 France Radioimmunoassay Market by End User
10.2.6.3 Italy Radioimmunoassay Market
10.2.6.3.1 Italy Radioimmunoassay Market by Type
10.2.6.3.2 Italy Radioimmunoassay Market by Application
10.2.6.3.3 Italy Radioimmunoassay Market by End User
10.2.6.4 Spain Radioimmunoassay Market
10.2.6.4.1 Spain Radioimmunoassay Market by Type
10.2.6.4.2 Spain Radioimmunoassay Market by Application
10.2.6.4.3 Spain Radioimmunoassay Market by End User
10.2.6.5 United Kingdom Radioimmunoassay Market
10.2.6.5.1 United Kingdom Radioimmunoassay Market by Type
10.2.6.5.2 United Kingdom Radioimmunoassay Market by Application
10.2.6.5.3 United Kingdom Radioimmunoassay Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Radioimmunoassay Market Overview
10.3.2 Asia-Pacific Radioimmunoassay Market Forecasts and Analysis
10.3.3 Asia-Pacific Radioimmunoassay Market Forecasts and Analysis - By Type
10.3.4 Asia-Pacific Radioimmunoassay Market Forecasts and Analysis - By Application
10.3.5 Asia-Pacific Radioimmunoassay Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Radioimmunoassay Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Radioimmunoassay Market
10.3.6.1.1 Australia Radioimmunoassay Market by Type
10.3.6.1.2 Australia Radioimmunoassay Market by Application
10.3.6.1.3 Australia Radioimmunoassay Market by End User
10.3.6.2 China Radioimmunoassay Market
10.3.6.2.1 China Radioimmunoassay Market by Type
10.3.6.2.2 China Radioimmunoassay Market by Application
10.3.6.2.3 China Radioimmunoassay Market by End User
10.3.6.3 India Radioimmunoassay Market
10.3.6.3.1 India Radioimmunoassay Market by Type
10.3.6.3.2 India Radioimmunoassay Market by Application
10.3.6.3.3 India Radioimmunoassay Market by End User
10.3.6.4 Japan Radioimmunoassay Market
10.3.6.4.1 Japan Radioimmunoassay Market by Type
10.3.6.4.2 Japan Radioimmunoassay Market by Application
10.3.6.4.3 Japan Radioimmunoassay Market by End User
10.3.6.5 South Korea Radioimmunoassay Market
10.3.6.5.1 South Korea Radioimmunoassay Market by Type
10.3.6.5.2 South Korea Radioimmunoassay Market by Application
10.3.6.5.3 South Korea Radioimmunoassay Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Radioimmunoassay Market Overview
10.4.2 Middle East and Africa Radioimmunoassay Market Forecasts and Analysis
10.4.3 Middle East and Africa Radioimmunoassay Market Forecasts and Analysis - By Type
10.4.4 Middle East and Africa Radioimmunoassay Market Forecasts and Analysis - By Application
10.4.5 Middle East and Africa Radioimmunoassay Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Radioimmunoassay Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Radioimmunoassay Market
10.4.6.1.1 South Africa Radioimmunoassay Market by Type
10.4.6.1.2 South Africa Radioimmunoassay Market by Application
10.4.6.1.3 South Africa Radioimmunoassay Market by End User
10.4.6.2 Saudi Arabia Radioimmunoassay Market
10.4.6.2.1 Saudi Arabia Radioimmunoassay Market by Type
10.4.6.2.2 Saudi Arabia Radioimmunoassay Market by Application
10.4.6.2.3 Saudi Arabia Radioimmunoassay Market by End User
10.4.6.3 U.A.E Radioimmunoassay Market
10.4.6.3.1 U.A.E Radioimmunoassay Market by Type
10.4.6.3.2 U.A.E Radioimmunoassay Market by Application
10.4.6.3.3 U.A.E Radioimmunoassay Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Radioimmunoassay Market Overview
10.5.2 South and Central America Radioimmunoassay Market Forecasts and Analysis
10.5.3 South and Central America Radioimmunoassay Market Forecasts and Analysis - By Type
10.5.4 South and Central America Radioimmunoassay Market Forecasts and Analysis - By Application
10.5.5 South and Central America Radioimmunoassay Market Forecasts and Analysis - By End User
10.5.6 South and Central America Radioimmunoassay Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Radioimmunoassay Market
10.5.6.1.1 Brazil Radioimmunoassay Market by Type
10.5.6.1.2 Brazil Radioimmunoassay Market by Application
10.5.6.1.3 Brazil Radioimmunoassay Market by End User
10.5.6.2 Argentina Radioimmunoassay Market
10.5.6.2.1 Argentina Radioimmunoassay Market by Type
10.5.6.2.2 Argentina Radioimmunoassay Market by Application
10.5.6.2.3 Argentina Radioimmunoassay Market by End User
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. RADIOIMMUNOASSAY MARKET, KEY COMPANY PROFILES
12.1. DIASOURCE IMMUNOASSAYS
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. BECKMAN COULTER, INC.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. IBL INTERNATIONAL
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. PERKINELMER, INC.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. DRG INTERNATIONAL, INC.
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. MP BIOMEDICALS, LLC
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. CISBIO
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. EURO DIAGNOSTICA AB
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. DIASORIN S.P.A.
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. EMD MILLIPORE
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies
1. DIAsource ImmunoAssays
2. Beckman Coulter, Inc.
3. IBL International (A Tecan Company)
4. PerkinElmer, Inc.
5. DRG International, Inc.
6. MP Biomedicals, LLC
7. Cisbio
8. Euro Diagnostica AB
9. DiaSorin S.p.A.
10. EMD Millipore
1. DIAsource ImmunoAssays
2. Beckman Coulter, Inc.
3. IBL International (A Tecan Company)
4. PerkinElmer, Inc.
5. DRG International, Inc.
6. MP Biomedicals, LLC
7. Cisbio
8. Euro Diagnostica AB
9. DiaSorin S.p.A.
10. EMD Millipore